Essential role of long non-coding RNAs in de novo chromatin
  modifications: The genomic address code hypothesis by Nishikawa, Ken & Kinjo, Akira R.
 1 
Essential role of long non-coding RNAs in de novo chromatin 
modifications: The genomic address code hypothesis 
 
 
Ken Nishikawa1 and Akira R. Kinjo2,* 
1National Institute of Genetics, Research Organization of Information and Systems, 
Mishima, Shizuoka, 411-8540, Japan; 2Institute for Protein Research, Osaka University, 
Suita, Osaka, 565-0871, Japan. 
*Correspondence to ARK (akinjo@protein.osaka-u.ac.jp). 
 
 
Abstract 
The epigenome, i.e. the whole of chromatin modifications, is transferred from mother to 
daughter cells during cell differentiation. When de novo chromatin modifications 
(establishment or erasure of, respectively, new or pre-existing DNA methylations and/or 
histone modifications) are made in a daughter cell, however, it has a different 
epigenome than its mother cell. Although de novo chromatin modifications are an 
important event that comprises elementary processes of cell differentiation, its 
molecular mechanism remains poorly understood. We argue in this Letter that a key to 
solving this problem lies in understanding the role of long non-coding RNAs (lncRNAs)- 
a type of RNA that is becoming increasingly prominent in epigenetic studies. Many 
studies show that lncRNAs form ribonucleo-protein complexes in the nucleus and are 
involved in chromatin modifications. However, chromatin-modifying enzymes lack the 
information about genomic positions on which they act. It is known, on the other hand, 
that a single-stranded RNA in general can bind to a double-stranded DNA to form a 
triple helix. If each lncRNA forms a ribonucleo-protein complex with 
chromatin-modifying enzymes on one hand and, at the same time, a triple helix with a 
genomic region based on its specific nucleotide sequence on the other hand, it can 
induce de novo chromatin modifications at specific sites. Thus, the great variety of 
lncRNAs can be explained by the requirement for the diversity of “genomic address 
codes” specific to their cognate genomic regions where de novo chromatin 
modifications take place. 
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Introduction 
      While all cells constituting a multicellular organism are derived from a single 
zygote to share the identical genome, they have different epigenomes depending on 
their cell types. The epigenome is a genome-wide pattern of gene-expression regulation 
embodied as chromatin modifications composed of DNA methylation as well as histone 
post-translational modifications, such as acetylation, methylation, phosphorylation and 
so on. The epigenome is maintained through cell division via epigenetic memory 
transfer from mother to daughter cells. This process is well illustrated by the 
maintenance of methylated DNA through DNA replication, where hemi-methylated 
nascent DNA strands are selectively methylated with DNA methyltransferase DNMT1 
to reproduce the original methylated DNA (Alberts et al. 2015).     
     Alteration of the epigenome, on the other hand, should occur in accordance with 
the progression of ontogenesis of an organism via cell differentiation. De novo 
chromatin modifications, including DNA methylations and histone modifications that 
are newly introduced or deleted, can be regarded as elementary steps of the epigenomic 
alteration. To date, the molecular mechanism of de novo chromatin modification is only 
poorly understood (Baubec et al. 2015). The difficulty of the problem may arise from 
the reciprocal relationship between the genome and the epigenome (Fig. 1). The 
downward blue arrows pointing from the epigenome to the genome in Fig. 1 represent 
the regulation of genomic information (gene expression), the molecular mechanisms of 
which are well understood. On the contrary, the upward red arrows pointing from the 
genome to the epigenome represent establishment or alteration of the epigenome 
(chromatin modifications) according to the information encoded on the genome 
possibly in conjunction with environmental cues (Fig. 1), the molecular mechanism of 
which is still unclear. Cell differentiation is a typical epigenetic phenomenon, during the 
course of which the epigenome is to be altered and a new epigenome specific to the 
terminally differentiated cell must be established. De novo chromatin modification may 
be a good starting point to tackle this basic biological issue.  
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Figure 1. A schematic view of genome, epigenome and phenotype in a cell. The genome, 
under a certain environment (blue horizontal arrow), determines the epigenome (upward 
red arrows) while the epigenome regulates the genome by activating or repressing gene 
expressions (downward blue arrows). The genome covered with a specific set of 
epigenomic marks determines the phenotype (the upward white arrow).  
———————————————————————————————————————————————————————————————————— 
 
 
Cell differentiation and de novo chromatin modifications 
      Suppose that new chromatin modifications that were absent in a mother cell are 
induced in the daughter cells over the course of cell differentiation. In the case of DNA 
methylation, for example, these correspond to de novo DNA methylations, that is, new 
methyl groups are added to previously unmethylated genomic sites. Similarly, it is 
expected that new histone modifications be introduced as cell differentiation proceeds. 
      Alteration of genome-wide chromatin modifications associated with 
embryogenesis as well as ontogenesis has been investigated by advanced sequencing 
techniques. Bisulphite sequencing, for instance, has helped to reveal the DNA 
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methylation landscapes of mammals and plants. In mammals, methylation 
reprogramming over all the genomic regions, except for imprinted genes, are performed 
twice in primordial germ cells and immediately after fertilization (Reik et al. 2001). 
After this the DNA methylation restarts around the time of implantation, and DNA 
methylations as well as histone modifications rapidly proceed throughout the 
embryogenesis (Vastenhouw and Schier 2012). This process must involve massive de 
novo chromatin modifications. 
      It was observed in mammals that the DNA methylation globally covers the 
genome, including intergenic DNA regions as well as gene-bodies, leaving only CpG 
islands mainly localized in gene promoters and cis-regulating enhancers unmethylated 
(Suzuki and Bird 2008). Promoter and/or enhancer DNA regions are differentially 
methylated depending on different cell lineages and developmental stages. The 
differential methylation along the course of cell differentiation must be brought about 
by de novo DNA methylation. There are, however, few investigations to elucidate the 
molecular details of de novo chromatin modifications. 
      In the case of new chromatin modifications such as de novo DNA methylations, 
we cannot assume that the modifications are copied from a mother cell to daughter cells. 
We propose that the key to understanding the de novo chromatin modification, or the 
problem of how new epigenomes are established (the upward red arrows in Fig. 1), 
resides in non-coding RNAs, among them, long non-coding RNAs in particular, that are 
massively transcribed from the genome, as recent experiments have elucidated. 
Non-coding RNAs are encoded in the genome and expressed as transcripts, which 
matches with the direction of the upward red arrows in Fig. 1.  
 
Long non-coding RNAs are abundant 
      In the early 21st century, the RIKEN Mouse Genome Project Team (Hayashizaki 
and Kanamori 2004), while analyzing cDNAs to identify genes in the mouse genome, 
discovered the existence of a wide variety of transcripts that did not correspond to any 
(protein-coding) genes (Katayama et al. 2005). Closer examination revealed that some 
of these transcripts overlapped with protein coding regions but were coded on the 
anti-sense strand while others are coded in intergenic regions. In short, as confirmed by 
later studies, the transcripts were found to originate from various genomic regions. 
Further studies have shown that a major fraction of the entire genome is transcribed and 
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the numerous transcripts with unknown functions are called “dark matter RNAs” 
(Kapranov and St Laurent 2012).  
      These transcripts are now called “non-protein coding RNAs” (ncRNAs) as they 
do not code proteins. Depending on their length, they are roughly classified into small 
non-coding RNAs (snRNA) consisting of 20-40 nucleotides or long non-conding RNAs 
(lncRNAs) of more than 200 nucleotides. Here, we focus on lncRNAs. Similarly to 
ordinary mRNAs, lncRNAs are transcribed by RNA polymerase II (Pol II), and the 
transcripts are processed with 5’ capping, splicing, and 3’ polyadenylation. However, 
lncRNAs do not contain ORFs and are not translated to proteins. Compared to mRNAs, 
lncRNAs are generally less conserved, which makes it difficult to predict their functions 
by sequence homology. In addition, they are highly tissue-specific or cell-type specific 
and many of them have a low expression level. 
      The number of identified lncRNA sequences encoded in human genomes has 
increased each year. This curious phenomenon is related to the tissue-specific nature of 
lncRNAs. A definitive method to identify genes is to express the genes in cells and to 
analyze the resulting cDNAs. This procedure is especially essential for identifying such 
“ambiguous” genes as those encoding lncRNAs. The high tissue specificity implies, 
however, that only a limited variety of lncRNAs are expressed in a particular cell. It 
follows that we need to study many kinds of tissues and cells to obtain a comprehensive 
list of lncRNAs. The number of lncRNA-coding genes in the human genome was once 
estimated to be around 15,000 (Derrien et al. 2012), which was less than that of the 
protein-coding genes (about 21,000). However, the number has gradually increased 
since then and we now (in 2015) know at least 58,000 lncRNA-coding genes (Iyer et al. 
2015). Iyer et al. (2015) have used many kinds of cancer cells to identify the lncRNAs 
(presumably because they could not use normal human cells for the investigation). 
These findings naturally raise the following two questions. (1) What are the roles of so 
many lncRNAs in the cells? (2) Why are so many lncRNAs necessary? 
 
LncRNAs are involved in various biological activities 
      The transcripts originating from about two thirds of the genomic DNAs of 
human and other mammals were called the “dark matter”, and researchers have 
wondered if they are of any biological significance or simply meaningless products 
transcribed from junk DNAs. Nevertheless, it has been reported that the number of 
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lncRNAs correlates with evolutionary complexity of organisms better than the genome 
size or the number of protein-coding genes (Kapusta and Feschotte 2014). This 
observation does suggest some biological significance of lncRNAs.  
      In fact, as studies of epigenetics advanced, lncRNAs were found to be involved 
in various important biochemical, cellular and developmental activities. Some 
well-known examples include such lncRNAs as Xist and Tsix that are involved in the 
inactivation of X chromosomes, or as Kcnq1ot1, Airn, and H19 in genome imprinting. 
The HOX gene cluster, a developmental-control DNA region important in 
embryogenesis, encodes the lncRNAs HOTTIP and HOTAIR that regulate the 
expression of HOXA genes and HOXD gene, respectively. More than 200 lncRNAs 
including lnc-RoR are known to be involved in the maintenance of the pluripotency of 
ES cells and/or iPS cells. LncRNAs also play vital roles in ontogenesis of tissues and 
organs and cell differentiation. Some examples are the following: Differentiation of the 
fat cell (ADINR and other several hundred lncRNAs); In the hematopoietic lineage, red 
blood cell differentiation (lnc-EPS and more than 400 lncRNAs) and T-cell 
differentiation (lnc-MAF4 and more than 100 lncRNAs); Development of the heart (e.g., 
Fendrr and Braveheart); Development of the brain and neurons (Evf2, RMST, Paupar, 
TUG1 and many other lncRNAs) (Lopez-Pajares 2016). 
      Many lncRNAs are expressed in various tissues and organs and are involved in 
their development and differentiation. Embryogenesis, ontogenesis and cell 
differentiation are accompanied with the establishment and alternation of epigenomes. 
Thus, it is natural to expect that lncRNAs play some role in the establishment and 
alteration of epigenomes (the upward red arrows in Fig. 1). This expectation was 
confirmed by recent studies using the epigenomic footprinting technique: the 
experiment was carried out for about 100 distinct cell types to indicate the concordance 
of cell-type specific transcription of lncRNAs with cell-type specific histone 
modifications (Amin et al. 2015). Now the question is: what are the precise roles of 
lncRNAs in epigenomic modifications? 
      To identify the function of lncRNAs, it is necessary to conduct experiments for 
each molecular species, which is in general more difficult than functional 
characterization of proteins. Thus, the number of functionally characterized lncRNAs is 
not large (about several hundreds). Nevertheless, we can already see a great diversity of 
their functions. One functional classification is to divide into two classes depending on 
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whether they function inside the nucleus or in the cytoplasm. Examples of those 
lncRNAs functioning in the nucleus include those involved in chromatin modifications. 
Those functioning in the cytoplasm include those anti-sense lncRNAs that hybridize 
with their mRNA counterparts to inhibit the translation.  Another classification is 
whether they are cis- or trans-regulatory. A lncRNA is said to be “cis-regulatory” if it 
functions in a genomic region near the coding region of the lncRNA itself. Otherwise, a 
lncRNA is said to be “trans-regulatory”. While most of lncRNAs are thought to be 
cis-regulatory, some examples of trans-regulatory lncRNAs are known. One famous 
example is the lncRNA HOTAIR which is encoded in one of Homeobox genes, HOXC 
gene cluster on human chromosome 12. HOTAIR represses the expression of the HOXD 
gene on human chromosome 2. Thus, HOTAIR clearly acts in-trans (Fatica and Bozzoni 
2014). 
 
LncRNAs have two functional domains 
      Looking across lncRNAs with known functions, we notice that many of them 
form a ribonucleo-protein complex. In the following, we focus on the cases where the 
protein components are chromatin-modifying enzymes. Accordingly, the corresponding 
lncRNAs function in the nucleus.  
      One of the best characterized lncRNA-binding proteins is the PRC2 (Polycomb 
repressive complex 2), a chromatin-modifying (histone-methylation) complex 
consisting of several proteins (Geisler and Paro 2015). PRC2 binds a lncRNA by 
recognizing its stem-loop secondary structure. The specificity of the RNA-protein 
binding is low in the following sense. Since any sufficiently long RNAs tend to contain 
some stem-loop secondary structures, PRC2 almost indiscriminately binds a wide range 
of RNAs to form a ribonucleo-protein complex. This promiscuous RNA binding ability 
of PRC2 (Davidovich et al. 2013) is an important factor that resolves the mystery of the 
asymmetry between the limited number of chromatin-modifying enzymes and the large 
variety of lncRNAs.  
      LncRNAs bind not only to proteins, but also to DNAs or other RNAs. A 
single-stranded RNA can hybridize with another single-stranded DNA or RNA. It is 
also known that a single-stranded RNA can bind to a double-stranded DNA to form a 
triple-stranded helix (Buske et al. 2011; Li Y et al. 2016). The hybridization of an RNA 
and DNA is supposedly highly specific as it is based on complementary base pairs. Thus, 
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a lncRNA can find DNA regions complementary to its DNA binding region to form a 
RNA-DNA helix. A longer binding region can achieve both higher affinity and higher 
specificity. 
      This picture of lncRNAs is in accordance with a previously proposed model in 
which lncRNAs have two functional domains (Johnson and Guigó 2014). According to 
this model, one functional domain of a lncRNA forms a stem-loop secondary structure 
which binds to a protein, and the other domain binds to the genomic DNA to form a 
triple helix. The two functional domains have distinctly different binding properties: the 
binding specificity is low in the former (RNA-protein) and high in the latter 
(RNA-DNA). That is, a particular protein can bind many different lncRNAs while a 
particular lncRNA can bind to only one (or few) specific DNA region(s). As already 
noted above, PRC2 can bind many lncRNAs by recognizing a stem-loop secondary 
structure. TrxG (Trithorax Group Complex) that has an “opposite” function to PRC2 
(TrxG activates gene expression by introducing a histone modification H3K4me3 while 
PRC represses gene expression by depositing H3K27me3) also binds lncRNAs in a 
similar manner (Fatica and Bozzoni 2014).  
Today, several lncRNAs are known to form both chromatin-modifying 
ribonucleo-protein complex and RNA-DNA triple helix, which we review next. 
 
LncRNAs anchor chromatin modifiers to genomic DNA sites 
      Schmitz et al. (2010) studied de novo DNA methylation of rDNA (ribosomal 
RNA-coding gene) promoter in mouse. They found that a kind of non-coding RNA 
(ncRNA), called promoter RNA (pRNA), is involved in the DNA methylation. pRNA is 
about 200-nt long and encoded on the rDNA promoter region. When transcribed, pRNA 
forms a triple helix about 20-nt long between a complementary pRNA sequence and 
double stranded DNA of the rDNA promoter region. The triple helix is recognized by de 
novo DNA methyltransferase DNMT3b for binding. DNMT3b, anchored to the 
genomic DNA via the pRNA, deposits the methyl group on a single cytosine of CpG 
sequence in the rDNA promoter, thereby hindering the binding of transcription factor 
TTF-1 to the promoter, which inactivates the transcription of the rDNA gene. 
Furthermore, the central region of the pRNA makes a stem-loop secondary structure 
which is recognized by a chromatin remodeling protein complex called NoRC. NoRC 
introduces histone modifications (H4K20me3 and H3K27me3) to the nearby chromatin 
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for heterochromatin formation, which, together with the DNA methylation, strongly 
represses the rDNA gene (Schmitz et al. 2010). This study showed that a single 
non-coding RNA, namely a pRNA, mediates not only de novo DNA methylations but 
also de novo histone modifications.  
      Other examples are also provided in a recent review by Li Y et al. (2016) who 
discussed the detailed mechanisms of triple helix formation by lncRNAs and DNAs in 
vivo. As they have already pointed out, six out of seven lncRNAs that they listed are 
reported to form triple helices as well as to recruit some chromatin modifiers (see Table 
1 in the paper by Li Y et al. 2016). We would like to point out that these proteins are 
also known to be involved in de novo chromatin modifications. The list includes, in 
addition to the pRNA discussed above, Fendrr (Foxf1 and Pitx2 genes and PRC2 and 
TrxG/MLL complexes), Khps1 (SPHK1 gene and the histone acetyltransferase 
p300/CBP), PARTICLE (MAT2A gene and PRC2), MEG3 (TGF- pathway genes and 
PRC2) and HOTAIR (PCDH7, HOXB2 and other genes, and PRC2 and the histone 
demethylase LSD1) (Li Y et al. 2016). The same, or similar, mechanism of de novo 
chromatin modifications is expected for other pRNAs as well as eRNAs (enhancer 
RNAs) that have been recently observed in various gene promoters and enhancers (Li 
W et al. 2016). 
      
Each lncRNA harbors the genomic address code of its own? 
      Chromatin-modifying enzymes do not have the positional information of the 
genomic sites on which they act. We propose that it is the role of lncRNAs to provide 
the missing positional information to the chromatin-modifying enzymes. Since this 
information specifies positions on the genome, we would like to call it “genomic 
address code (GAC)”, rather than “cellular address code” (Batista and Chang 2013). 
Several concrete examples were described in the previous section. We predict the 
existence of GAC regions to be ubiquitous in those lncRNAs that bind to de novo 
chromatin-modifying enzymes such as PRC2 and TrxG. Although there are only a 
handful experimental studies to date confirming the existence of GACs in lncRNAs, if it 
is indeed the case, we can clearly understand the role of lncRNAs in epigenomic 
regulation. That is, a lncRNA binds a chromatin-modifying enzyme by using its 
stem-loop and anchors it to a particular site of the genomic DNA specified by its GAC 
by forming a triple helix, and the enzyme then modifies the chromatin. If this 
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hypothesis holds, it is possible for chromatin-modifying complexes to be recruited to 
arbitrary genomic sites simply by modifying the information of the GAC sequence in 
lncRNAs. This mechanism provides a simple way to increase the complexity of gene 
expression patterns by increasing the variety of lncRNAs, which may account for the 
correlation between the number of lncRNAs and evolutionary complexity of organisms 
(Kapusta and Feschotte 2014). We can thus explain the molecular mechanism of de 
novo chromatin modifications and understand not only that lncRNAs are indispensable 
factors in the process of establishing and altering epigenomes (the upward red arrows in 
Fig. 1), but also why tens of thousands of lncRNAs are required for determining the 
epigenome in various types of cells. 
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